Key Financial Data Of Reporting Company

STELLA PHARMA CORPORATION - Filing #7350910

Concept As at
2023-12-31
2023-10-01 to
2023-12-31
2023-04-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-12-31
As at
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
200,193,000 JPY
229,067,000 JPY
175,169,000 JPY
Ordinary profit (loss)
-466,654,000 JPY
-775,974,000 JPY
-480,498,000 JPY
Profit (loss)
-469,561,000 JPY
-778,824,000 JPY
-483,220,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
2,938,110,000 JPY
3,300,417,000 JPY
3,079,623,000 JPY
Total number of issued shares
31,225,500 xbrli:shares
29,966,300 xbrli:shares
28,676,100 xbrli:shares
Net assets
2,671,200,000 JPY
2,752,502,000 JPY
2,609,781,000 JPY
Total assets
3,926,718,000 JPY
4,329,053,000 JPY
4,053,152,000 JPY
Dividend paid per share
Basic earnings (loss) per share
-5.24
-15.19
-26.97
-16.85
-4.85
Diluted earnings per share
Equity-to-asset ratio
0.678 xbrli:pure
0.633 xbrli:pure
0.641 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.